These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6193472)

  • 21. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Coker DD; Elias EG; Chretien PB; Gray WC; Coleman JJ; Zentai TA; Didolkar MS; Morris DM; Viravathana T; Hebel JR
    Head Neck Surg; 1981; 4(2):111-7. PubMed ID: 6171545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A trial of outpatient chemotherapy for recurrent head and neck tumors.
    Huang AT; Lucas VS; Baughn SG; Cole TB
    Cancer; 1980 Apr; 45(8):2038-41. PubMed ID: 6154522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A; Cummings G; Al-Sarraf M
    Cancer; 1983 Aug; 52(3):399-403. PubMed ID: 6190548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy with methotrexate, bleomycin and hydroxyurea with or without cisplatin in advanced squamous cell carcinoma of the head and neck: a study of the Swiss Group for Clinical Cancer Research (SAKK).
    Abele R; Honegger HP; Wolfensberger M; Grossenbacher R; Mermillod B; Cavalli F
    Prog Clin Biol Res; 1985; 201():169-75. PubMed ID: 2419916
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
    Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
    Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
    Klima A; von Ilberg C; Bergmann L; Zoubek A; Klippstein T; Mitrou PS; Szepesi S
    HNO; 1987 Feb; 35(2):78-83. PubMed ID: 2437086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy with cis-diamminedichloroplatinum, oncovin, and bleomycin (COB) in advanced head and neck cancer: phase II.
    Amer MH; Izbicki RM; Vaitkevicius VK; Al-Sarraf M
    Cancer; 1980 Jan; 45(2):217-23. PubMed ID: 6153149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH
    Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
    Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
    Am J Med; 1983 Oct; 75(4):645-52. PubMed ID: 6194685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
    Gonzalez MF; Valdivieso JG; Sartiano GP
    Oncology; 1984; 41(6):377-82. PubMed ID: 6209601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer.
    Israel L; Aguilera J; Soudant J; Penot JC; Breau JL; Morere JF
    Am J Clin Oncol; 1983 Jun; 6(3):305-11. PubMed ID: 6189388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL; Stewart J; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy of squamous cell cancer of the head and neck.
    Gill PG; Hains JD; Iyer P; Rozenbilds JG; Ahmad A; Abbott RL; David DJ; Ward GG; Brown MW; Harvey ND
    Med J Aust; 1983 May; 1(10):463-6. PubMed ID: 6188946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer.
    Kies MS; Gordon LI; Hauck WW; Krespi Y; Ossoff RH; Pecaro BC; Yuska C; Lamut CH; Brand WN; Chang SK
    Otolaryngol Head Neck Surg; 1985 Apr; 93(2):199-205. PubMed ID: 2581211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination chemotherapy with vinblastine, bleomycin, and cis-diamminedichloroplatinum (II) in squamous cell carcinoma of the head and neck.
    Brown AW; Blom J; Butler WM; Garcia-Guerrero G; Richardson MF; Henderson RL
    Cancer; 1980 Jun; 45(11):2830-5. PubMed ID: 6155199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
    Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.
    Elias EG; Chretien PB; Monnard E; Khan T; Bouchelle WH; Wiernik PH; Lipson SD; Hande KR; Zentai T
    Cancer; 1979 Mar; 43(3):1025-31. PubMed ID: 85477
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.